Gene therapy towards a clinical trial for gamma-sarcoglycanopathy, limb-girdle muscular dystrophy

(AFM-T é l é thon) Isabelle Richard's team, a CNRS researcher in an Inserm unit at Genethon, the AFM-Telethon laboratory, has demonstrated the efficacy of gene therapy and determined the effective dose for treating a rare muscle disease, gamma-sarcoglycanopathy, in mouse models of the disease. Based on these encouraging results, published in Molecular Therapy: Methods and Clinical Development, the researchers are preparing a clinical trial.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news